stockrow
Saturday 7 November 2026
Export DBVT’s income statement to Excel — free account
DBV Technologies S.A.
DBVT Healthcare Biotechnology
DBV Technologies S.A.’s revenue for fiscal 2025 (year ended December 2025) was $5.6 million, up 35.8% from fiscal 2024.
- Revenue
- −42.9%
- EPS
- +40.4%
- Free cash flow
- −64.9%
Quarter to September 2026, against a year earlier
10.57
0.77
+7.86%
Follow DBVT
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 5 | 4 |
+8 more TTM periods Free account |
| (205.75%) | (142.63%) | (158.81%) | (149.73%) | ||
| (127.19%) | (95.98%) | (105.66%) | (98.17%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(145.33%) | (111.85%) | (81.76%) | (88.90%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2.13) | (1.97) | (1.77) | (4.36) | |
Free Cash Flow |
(191.71) | (170.57) | (151.51) | (121.74) | |
Capital Expenditures |
(3.33) | (1.29) | (0.93) | (0.56) | |
| Other line items | |||||
Cash ROIC |
(60.96%) | (50.87%) | (34.66%) | (33.54%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | 0.01 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3,867.29% | 2,554.34% | 2,241.67% | 2,070.30% | |
Selling, General and Administrative Expense of Revenue |
1,804.34% | 1,146.88% | 791.67% | 638.93% | |
Share Based Compensation of Revenue |
342.26% | 171.94% | 104.38% | 95.58% | |
Interest Coverage |
— | — | 361.84 | — | |
Operating CF/Net income |
0.91 | 0.96 | 0.90 | 0.82 | |
Depreciation/Fixed assets |
0.24 | 0.31 | 0.31 | 0.31 | |
Capex/Depreciation |
(1.19) | (0.43) | (0.30) | (0.18) | |
Revenue per Share |
0.04 | 0.06 | 0.07 | 0.20 | |
Operating CF per Share |
(2.09) | (1.95) | (1.76) | (4.34) | |
Capex per Share |
(0.04) | (0.01) | (0.01) | (0.02) | |
Capex to Sales |
0.89 | 0.26 | 0.16 | 0.10 |
Columns are period end dates · fundamentals updated 2 Nov 2026